Drug Interactions Database

6278 interactions from BNF 85 - Check your medicines

Source: BNF 85
Severity: All 6278 Severe 944 Moderate 1418 Unknown 3916
tamoxifen phenytoinandphenytoinmightdecreasetheconcentrationoftamoxifen

increases concentration

Unknown Anecdotal
tapentadol drugsthatcauseserotoninsyndrome

increases risk of serotoninsyndrome

Unknown Theoretical
tapentadol seetablep

increases risk of serotoninsyndrome

Unknown Theoretical
taxanes atorvastatin

affects exposure

Unknown Theoretical
taxanes fexofenadine

affects exposure

Unknown Theoretical
taxanes glibenclamide

affects exposure

Unknown Theoretical
taxanes pravastatin

affects exposure

Unknown Theoretical
taxanes repaglinide

affects exposure

Unknown Theoretical
taxanes rosuvastatin

affects exposure

Unknown Theoretical
taxanes simvastatin

affects exposure

Unknown Theoretical
taxanes statins

affects exposure

Unknown Theoretical
taxanes valsartan

affects exposure

Unknown Theoretical
tedizolid imatinib

increases exposure

Unknown Theoretical
tedizolid lapatinib

increases exposure

Unknown Theoretical
tedizolid sulfasalazine

increases exposure

Unknown Study
tedizolid topotecan

increases exposure

Unknown Study
tegafur coumarins

increases anticoagulant effect

Unknown Theoretical
telotristatethyl benzodiazepines

decreases exposure

Unknown Study
telotristatethyl doravirine

decreases exposure

Unknown Theoretical
telotristatethyl midazolam

decreases exposure

Unknown Study
temsirolimus amlodipine

increases risk of angioedema

Unknown Theoretical
temsirolimus calciumchannelblockers

increases risk of angioedema

Unknown Theoretical
temsirolimus felodipine

increases risk of angioedema

Unknown Theoretical
temsirolimus lacidipine

increases risk of angioedema

Unknown Theoretical
temsirolimus lercanidipine

increases risk of angioedema

Unknown Theoretical
temsirolimus nicardipine

increases risk of angioedema

Unknown Theoretical
temsirolimus nifedipine

increases risk of angioedema

Unknown Theoretical
temsirolimus nimodipine

increases risk of angioedema

Unknown Theoretical
tepotinib aliskiren

increases concentration

Unknown Study
tepotinib antihistamines,non-sedating

increases concentration

Unknown Study
tepotinib atorvastatin

increases exposure

Unknown Theoretical
tepotinib colchicine

increases concentration

Unknown Study
tepotinib dabigatran

increases exposure

Unknown Study
tepotinib digoxin

increases concentration

Unknown Study
tepotinib docetaxel

increases concentration

Unknown Study
tepotinib everolimus

increases concentration

Unknown Study
tepotinib fexofenadine

increases concentration

Unknown Study
tepotinib fluvastatin

increases exposure

Unknown Theoretical
tepotinib loperamide

increases concentration

Unknown Study
tepotinib paclitaxel

increases concentration

Unknown Study
tepotinib rosuvastatin

increases exposure

Unknown Theoretical
tepotinib sirolimus

increases concentration

Unknown Study
tepotinib statins

increases exposure

Unknown Theoretical
tepotinib sulfasalazine

increases exposure

Unknown Theoretical
tepotinib talazoparib

increases concentration

Unknown Study
tepotinib taxanes

increases concentration

Unknown Study
tepotinib thrombininhibitorse

increases exposure

Unknown Study
tepotinib topotecan

increases concentration

Unknown Study
terbinafine betablockers,selective

increases exposure

Unknown Study
terbinafine codeine

decreases efficacy

Unknown Theoretical
Prev 1 ... 118 119 120 121 122 ... 126 Next
6278 interactions
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.